The Latest Evidence and Barriers to the Integration of Emerging Targeted Therapies in Adult Diffuse Low-Grade Glioma Care

The Latest Evidence and Barriers to the Integration of Emerging Targeted Therapies in Adult Diffuse Low-Grade Glioma Care

In this concise on-demand video, explore the emerging targeted therapies for the treatment of adult diffuse low-grade gliomas. Hear two leading low-grade glioma experts discuss the latest evidence and how to overcome barriers to the integration of emerging targeted therapies in low-grade glioma care. Don’t miss the opportunity to visualize the underlying mechanisms of action of these targeted therapies through a unique whiteboard animation video!

  • Provider:PRIME Education, Inc. (PRIME®)
  • Activity Link: https://primeinc.org/online/examining-latest-data-poised-advance-glioma-care-micro-learning-approach
  • Start Date: 2024-04-26 05:00:00
  • End Date: 2024-04-26 05:00:00
  • Credit Details: IPCE Credits: 0.75 hours
    AAPA Category 1 Credit™️: 0.75 hours
    AMA PRA Category 1 Credit™️: 0.75 hours
    Nursing: 0.75 hours
    Pharmacy: 0.75 hours
  • Commercial Support: Source: Servier Pharmaceuticals - Amount: 54750.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner/Team Competence, Learner/Team Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.